Skip to main content
OpenTrials

Clinical trial condition

Pulmonary Alveolar Proteinosis, Acquired

Explore clinical trials studying Pulmonary Alveolar Proteinosis, Acquired. Study availability and eligibility vary by location and protocol.

10 public trials 1 recruiting study
Refine in advanced search Browse all conditions

Pulmonary Alveolar Proteinosis, Acquired trial results

Completed

Efficacy and Safety of Inhaled Molgramostim (rhGM-CSF) in Autoimmune Pulmonary Alveolar Proteinosis

NCT02702180

Conditions
Autoimmune Pulmonary Alveolar Proteinosis, Pulmonary Alveolar Proteinosis, Acquired
Locations
  • UCLA Los Angeles, California, United States
  • University of Florida Gainesville, Florida, United States
  • Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States
  • Royal Prince Alfred Hospital Sydney, New South Wales, Australia
View all 30 locations
View Trial Details
Active, Not Recruiting

Clinical Trial of Inhaled Molgramostim Nebulizer Solution in Autoimmune Pulmonary Alveolar Proteinosis (aPAP)

NCT04544293

Conditions
Autoimmune Pulmonary Alveolar Proteinosis, Pulmonary Alveolar Proteinosis, Acquired
Locations
  • University Of Arkansas For Medical Services Little Rock, Arkansas, United States
  • UCLA David Geffen School of Medicine Los Angeles, California, United States
  • National Jewish Health Denver, Colorado, United States
  • Yale University New Haven, Connecticut, United States
View all 54 locations
View Trial Details

Related conditions